Career history of Jeffrey Molldrem
Former positions of Jeffrey Molldrem
| Companies | Position | Start | End |
|---|---|---|---|
The Vaccine Co.
 The Vaccine Co. BiotechnologyHealth Technology The Vaccine Co. develops therapeutic vaccines for the treatment of leukemias and other types of cancers. Its products include Proteinase 3 PR1 peptide vaccine, Proteinase 3 PR1 peptide vaccine, and Myelodysplastic Syndrome. The company was founded by Jeffrey Molldrem, Ronald B. Garren, Gregory C. Thayer, and Craig S. Rosenfeld in 2003 and is headquartered in San Francisco, CA. | Director/Board Member | 2002-12-31 | - |
| Founder | 2009-10-31 | - | |
| Corporate Officer/Principal | 2003-06-30 | 2009-10-31 |
Training of Jeffrey Molldrem
| University of Minnesota | Doctorate Degree |
Statistics
International
| United States | 3 |
Operational
| Director/Board Member | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
The Vaccine Co.
The Vaccine Co. BiotechnologyHealth Technology The Vaccine Co. develops therapeutic vaccines for the treatment of leukemias and other types of cancers. Its products include Proteinase 3 PR1 peptide vaccine, Proteinase 3 PR1 peptide vaccine, and Myelodysplastic Syndrome. The company was founded by Jeffrey Molldrem, Ronald B. Garren, Gregory C. Thayer, and Craig S. Rosenfeld in 2003 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Molldrem
- Experience
